Diabetic Nephropathy

Stem cells from bone marrow are being investigated as a possible treatments for diabetic nephropathy. Click on the link provided to find out more about the trial. It remains too early to know if the approach will be suitable. We need evidence collected in clinical trials to determine if a proposed stem cell treatment is both safe and effective.

tagged as Diabetic Nephropathy

  • Investigation on Autologous Mesenchymal Stem Cell Transplantation in Diabetic Nephrophaty Location: Iran
    Overview: This trial aims to investigate the use of the patient's mesenchymal stem cells in the treatment of nephropathy and kidney failure in patients with type 1 diabetes. The trial is being conducted by the Endocrinology and Metabolism Research Institute in Teheran and proposes to recruit 20 patients by end 2013. The participants will receive an intravenous infusion of mesenchymal stem cells obtained from their own bone marrow and expanded in the laboratory. Participants will be monitored for complications and changes in their condition.
    Link to Clinical Registry
    Trial Design: Safety and Efficacy Study
    Status: Open - Recruiting
    Stem Cell: Adult Bone Marrow Stem Cells